DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the company's ...

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

Dexcom, the San Diego-based maker of continuous glucose monitors for diabetes patients and prediabetics, announced Wednesday ...

DexCom, Inc. ( NASDAQ: DXCM) Baird Global Healthcare Conference 2025 September 10, 2025 2:00 PM EDT Next presentation this afternoon is from DexCom, a leader in developing and commercializing ...

We came across a bullish thesis on DexCom, Inc. on Flyover Stocks Substack by Todd Wenning. In this article, we will ...

Insulet’s chief growth officer said: “colour has the power to differentiate a brand,” with mango orange adorning Omnipod’s ...

Dexcom, fabricante de monitores continuos de glucosa para pacientes con diabetes y prediabetes, con sede en San Diego, anunció el miércoles el despido de unos 350 trabajadores, el 3% de su plantilla ...

The Kaleido insulin patch pump worn on the arm. [Image courtesy of ViCentra] For ViCentra CEO Tom Arnold, the journey to lead a developer of insulin delivery technologies was a personal one. A veteran ...

The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin. Biolinq says its ...

Dexcom, Inc, has issued a recall for G7 Apps and ONE+ Apps because of a software design error failing to alert users of ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best strong buy growth stocks to buy now. On August 21, Argus initiated coverage of DexCom, Inc. (NASDAQ:DXCM) with a Buy rating and $100 price target. Why ...